Is MAP1B p.Pro705Leu (c.2114C>T) pathogenic?

MAP1B p.Pro705Leu (c.2114C>T) is classified Likely benign in MAP1B (ClinVar, Single submitter, 1 submitter; last evaluated 2022-12-13). AlphaMissense: likely benign (0.0675); Ultra-rare (popmax 0.0187%, amr); Associated with Inborn genetic diseases.

What condition is associated with MAP1B p.Pro705Leu (c.2114C>T)?

MAP1B p.Pro705Leu (c.2114C>T) is associated with Inborn genetic diseases (ClinVar).

How common is MAP1B p.Pro705Leu (c.2114C>T) in the general population?

MAP1B p.Pro705Leu (c.2114C>T) is ultra-rare (popmax 0.0187%, amr) (gnomAD).

What do computational predictors say about MAP1B p.Pro705Leu (c.2114C>T)?

AlphaMissense predicts likely benign (score 0.0675) — an in-silico prediction, not a clinical call.

MAP1B p.Pro705Leu

c.2114C>T · rs775520012 · VCV3122699

Likely benign Single submitter

Classification

Likely benign

ClinVar

Review

Single submitter ★☆☆☆

ClinVar · 1 submitter

AlphaMissense

likely benign

0.0675 · ACMG-weighted

gnomAD v4.1

Rare

ultra-rare (popmax 0.0187%, amr)

Missense predictors

0/3 damaging

AlphaMissense, REVEL, SaProt

Conditions

Inborn genetic diseases

Computational evidence

Protein change
AlphaMissense	0.0675	likely benign
REVEL	0.131	moderately benign-leaning
SaProt	LLR -8.85	tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 6	GERP 2.1, phastCons 1
Regional constraint	o/e 0.91	unconstrained · MANE · 5,330 bp · p 1.3e-05 · regional, not allelic
Overall
CADD	22.6	PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.0187% Admixed American · 10/53,458 alleles

Filtering AF 0.0101% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00766%

Overall 0.00391% 62/1,586,390 alleles · ultra-rare exomes 57/1,435,168 · genomes 5/151,222 · joint denominator

Ancestry group	Frequency	1 in
Admixed Americangrpmax	0.0187%	5,346
South Asian	0.0153%	6,538
East Asian	0.00677%	14,763
Remaining individualsnot grpmax-eligible	0.00326%	30,699
European (non-Finnish)	0.00282%	35,479
African / African-American	0.00138%	72,668

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: MAP1B
Protein: p.Pro705Leu
Coding: c.2114C>T
MANE Select: NM_005909
dbSNP: rs775520012
Type: single nucleotide variant
Location: chr5:72195469 (GRCh38)
Gene constraint: LOEUF 0.105 · pLI 1.00 (gnomAD)
Structure: AlphaFold pLDDT 46.18
Residue 705: the 'disordered' region; a UniProt-annotated variant site (in pvnh9)

Full MAP1B gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

Inborn genetic diseases — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Similar variants

MAP1B p.Pro705= Likely benign same residue
MAP1B p.Ala966Val Uncertain significance ★★ ⚠ same condition
MAP1B p.Asp1480Tyr Uncertain significance ★★ ⚠ same condition
MAP1B p.Asp1993Gly Uncertain significance ★★ ⚠ same condition
MAP1B p.Glu1944Lys Uncertain significance ★★ ⚠ same condition
MAP1B p.Glu2435Val Uncertain significance ★★ ⚠ same condition
MAP1B p.Gly919Arg Uncertain significance ★★ ⚠ same condition
MAP1B p.Gly932Ser Uncertain significance ★★ ⚠ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/map1b-p-pro705leu (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown